ストックスクリーナーアプリを入手
240.00
1.46%
-3.56
アフターアワーズ：
240.00
前日終値:
$243.56
開ける：
$242.7
24時間の取引高:
348.06K
Relative Volume:
1.32
時価総額：
$6.68B
収益：
$2.58B
当期純損益:
$-778.69M
株価収益率:
-8.7816
EPS:
-27.33
ネットキャッシュフロー:
$223.75M
1週間 パフォーマンス:
-2.96%
1か月 パフォーマンス:
-9.49%
6か月 パフォーマンス:
-28.93%
1年 パフォーマンス:
-29.20%
1日の値動き範囲:
$237.92
$245.52
1週間の範囲:
$235.84
$249.37
52週間の値動き範囲:
$235.84
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
名前
Bio Rad Laboratories Inc
セクター
電話
(510) 724-7000
住所
1000 ALFRED NOBEL DRIVE, HERCULES
BIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
240.00 | 6.68B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
131.69 | 228.35B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
101.24 | 149.58B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
373.30 | 142.54B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.49 | 113.81B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.87 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-04-03 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-12-07 | 開始されました | UBS | Buy |
| 2023-06-16 | 開始されました | Wells Fargo | Overweight |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-01-28 | 繰り返されました | Citigroup | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2018-10-17 | 開始されました | Goldman | Buy |
| 2018-09-20 | 開始されました | Morgan Stanley | Equal-Weight |
| 2018-02-16 | ダウングレード | CL King | Buy → Neutral |
| 2017-07-13 | 開始されました | Wells Fargo | Outperform |
| 2017-06-28 | アップグレード | Deutsche Bank | Hold → Buy |
| 2017-01-18 | 開始されました | Deutsche Bank | Hold |
| 2016-10-13 | 開始されました | CL King | Buy |
| 2015-05-06 | 繰り返されました | Jefferies | Buy |
| 2009-12-18 | 開始されました | Maxim Group | Buy |
| 2009-11-06 | 開始されました | Jefferies & Co | Buy |
| 2009-07-17 | 開始されました | Soleil | Buy |
| 2007-09-26 | 開始されました | Banc of America Sec | Buy |
| 2007-02-23 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Bio Rad Laboratories Inc (BIO) 最新ニュース
Autoimmune Disease Diagnostics Market Is Booming So Rapidly - openPR.com
Cell-Free Protein Expression Market Detailed Analysis - openPR.com
Dna Sequencing Equipment And Services Market 2025: Sustainable - openPR.com
Biomarker Research Services Market Is Booming Worldwide - openPR.com
Porphyria Treatment Market Growth in Future Scope 2025-2032 | - openPR.com
Jefferies cuts Bio-Rad Labs target to $285, maintains Hold By Investing.com - Investing.com Canada
Life Science Products Market Projected To Witness Substantial - openPR
HIV Diagnostics Test Market Projected To Witness Substantial - openPR
Cancer Biomarkers Market: Emerging Trends, Growth Drivers & - openPR
Bio-Rad stock touches 52-week low at $243.94 amid market shifts By Investing.com - Investing.com South Africa
Bio-Rad stock touches 52-week low at $243.94 amid market shifts - Investing.com Australia
Chromatography Data System Market Generated Opportunities, - openPR
High End Cellomics Market Set to Witness Significant Growth - openPR
Flow Cytometry Market Is Booming Worldwide | Luminex - openPR
Bio-Rad Laboratories (BIO) is a Classic Ariel Stock: Ariel Fund - MSN
Bio-Rad Laboratories’ (BIO) Growth Tailwinds Are Delayed, Not Derailed - MSN
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts -March 24, 2025 at 04:06 pm EDT - Marketscreener.com
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts - StreetInsider.com
Oncocyte Secures Game-Changing Bio-Rad Deal and $57M War Chest for $1B Market Push - StockTitan
Clinical Diagnostics Market is Projected to Increase at a CAGR - openPR
Monoclonal Antibody Diagnostic Reagents Market Growth - openPR
Oncocyte secures $29.1 million to advance FDA assay - MSN
Bio-Rad Launches XP-Design Assay Salmonella Serotyping Solution for Food Safety Testing - Technology Networks
Enzyme Linked Immunosorbent Assay Market Growth Analysis: - openPR
South East Asia And South Asia Industrial Microbiology Market - openPR
Life Science Products Market Is Booming Worldwide 2025-2032 | - openPR
Hemoglobin A1c Testing Devices Market Projected To Witness - openPR
Learn to Evaluate (BIO) using the Charts - Stock Traders Daily
Does Bio-Rad Laboratories (NYSE:BIO) Have A Healthy Balance Sheet? - simplywall.st
Cancer Biomarkers Market Size, Share, Growth Factors, - openPR
Blood Typing Analysis Report 2024: Market Set to Surge to $6.50 Billion by 2034, PCR and Microarray Techniques Pave the Way - GlobeNewswire Inc.
Blotting Machine Market Future Business Opportunities - openPR
Where are the Opportunities in (BIO.B) - Stock Traders Daily
The Future of Genetic Testing: Industry Growth, Trends & Key - openPR
Biomarker Research Services Market Projected To Witness Substantial Growth, 2025-2032:Bio-Rad Laboratories, - EIN News
Transcriptomics Technologies Market Future Business - openPR
Salmonella serotyping solution enhances food safety testing - Labmate Online
New XP-Design Assay Salmonella Serotyping Solution for Rapid, Accurate Food Safety Testing - Food Safety Magazine
Bio-Rad launches XP-Design Assay Salmonella Serotyping Solution for rapid and accurate food safety testing - Cambridge Network
Newborn Screening Market Growth in Future Scope 2025-2032 | - openPR
Charles Schwab Investment Management Inc. Boosts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Laboratory Supplies Market Generated Opportunities, Future - openPR
Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.
ChemiDoc Go Imaging System - the-scientist.com
HIV Rapid Test Kits Market Focused Insights 2025-2030: Abbott, Bio-Rad, and bioMerieux Strengthen Market Position Amid Rising Competition - Yahoo Finance
Stem Cell Assay Market Demand, Industry Growth and Future Scope - openPR
Empowering Growth: Vector Purification Market 2025 - openPR
Clinical Biomarkers Market Key Players Analysis- Johnson & - openPR
Expanded kit range enhances AAV vector characterisation - Labmate Online
Neurological Biomarkers: Global Market Review 2020-2024 and - GlobeNewswire
Neurological Biomarkers: Global Market Review 2020-2024 and Forecast to 2030, Featuring Analysis of PerkinElmer, Abbott Labs, Thermo Fisher Scientific, Banyan Biomarkers, Bio-Rad Labs & More - Yahoo Finance
Bio Rad Laboratories Inc (BIO) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
大文字化:
|
ボリューム (24 時間):